Harris unveils NHIN CONNECT installation wizard

Jeff Byers | | Health Exec | Informatics
Harris has released an open-source CONNECT installation wizard to reduce the time required to link healthcare organizations to the Nationwide Health Information Network (NHIN).

The CONNECT open-source application is a gateway to the NHIN enabling federal agencies and private sector health entities to securely exchange electronic patient information, according to Harris.

Developed by Harris under contract for the Federal Health Architecture within the Office of the National Coordinator for Health IT, the CONNECT wizard provides step-by-step instructions for installing the NHIN gateway, the Melbourne, Fla.-based company stated.

The wizard completes tasks that previously had to be handled manually, like modifying configuration settings, and determines if any additional software is needed for installation and downloads and installs the appropriate files, Harris added.

Jeff Byers

Related Content

Alabama security breach exposes personal information of cardiologists, heart patients
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Best in KLAS 2024: New rankings for cardiovascular information systems, hemodynamic solutions
Best in KLAS 2024 rankings released, showcasing medical imaging IT systems
Cloud image storage for radiology is a growing trend in healthcare
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.